GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Policy Acquisition Expense

MindBio Therapeutics (XCNQ:MBIO) Policy Acquisition Expense


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


MindBio Therapeutics Business Description

Traded in Other Exchanges
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.
Executives
Accelerative Investments Pty Ltd Director